Science Explorer Back to mapMap
Discussion
Company · Rome · Italy

AlmavivA (Italy)

almaviva.itROR OpenAlex
Research works
19
▲ 196% vs 2018-21
Citations
86
4.6 per fractional work
Top-10% rate
4.9%
all institutions 10.0%
Open access
43%
world 40%
International
15%
world 18%
AlmavivA (Italy)

Not ranked overall: AlmavivA (Italy) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does AlmavivA (Italy) work in?

In all years, 57% of research at AlmavivA (Italy) is in Physical Sciences, 23% in Social Sciences. Its largest fields are Computer Science (27%), Social Sciences (15%), Engineering (13%). It does 1.3× the world's share of Physical Sciences.

Physical Sciences: 11 fractional works · 57.2% of its workComputer Science: 5 fractional works · 27.3% of its workArtificial Intelligence: 2 fractional works · 11.3% of its workComputer Vision and Pattern Recognition: 2 fractional works · 8.2% of its workInformation Systems: 1 fractional works · 4.2% of its workComputer Networks and Communications: 0 fractional works · 2.3% of its workSignal Processing: 0 fractional works · 0.9% of its workHuman-Computer Interaction: 0 fractional works · 0.4% of its workEngineering: 2 fractional works · 12.8% of its workMedia Technology: 1 fractional works · 3.6% of its workOcean Engineering: 0 fractional works · 2.7% of its workBuilding and Construction: 0 fractional works · 2.1% of its workControl and Systems Engineering: 0 fractional works · 1.5% of its workElectrical and Electronic Engineering: 0 fractional works · 1.5% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.9% of its workBiomedical Engineering: 0 fractional works · 0.6% of its workEnvironmental Science: 2 fractional works · 11.2% of its workEnvironmental Engineering: 1 fractional works · 4.4% of its workEcology: 0 fractional works · 2.3% of its workGlobal and Planetary Change: 0 fractional works · 2.3% of its workNature and Landscape Conservation: 0 fractional works · 0.9% of its workPollution: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEarth and Planetary Sciences: 1 fractional works · 5.9% of its workAtmospheric Science: 0 fractional works · 2.3% of its workEarth-Surface Processes: 0 fractional works · 1.8% of its workGeology: 0 fractional works · 1.8% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 4 fractional works · 23.2% of its workSocial Sciences: 3 fractional works · 15.5% of its workEducation: 1 fractional works · 4.4% of its workPolitical Science and International Relations: 1 fractional works · 3.6% of its workGeography, Planning and Development: 0 fractional works · 1.8% of its workSafety Research: 0 fractional works · 1.8% of its workSociology and Political Science: 0 fractional works · 1.8% of its workTransportation: 0 fractional works · 1.2% of its workHealth: 0 fractional works · 0.9% of its workBusiness, Management and Accounting: 1 fractional works · 4.9% of its workManagement Information Systems: 0 fractional works · 2.3% of its workStrategy and Management: 0 fractional works · 1.1% of its workAccounting: 0 fractional works · 0.9% of its workMarketing: 0 fractional works · 0.5% of its workEconomics, Econometrics and Finance: 0 fractional works · 2.4% of its workEconomics and Econometrics: 0 fractional works · 2.4% of its workDecision Sciences: 0 fractional works · 0.4% of its workInformation Systems and Management: 0 fractional works · 0.4% of its workHealth Sciences: 2 fractional works · 10.5% of its workMedicine: 2 fractional works · 10.5% of its workOncology: 1 fractional works · 3.4% of its workInfectious Diseases: 0 fractional works · 2.4% of its workSurgery: 0 fractional works · 1.0% of its workObstetrics and Gynecology: 0 fractional works · 0.9% of its workEmergency Medicine: 0 fractional works · 0.6% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.6% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.4% of its workEpidemiology: 0 fractional works · 0.4% of its workGeriatrics and Gerontology: 0 fractional works · 0.4% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.4% of its workLife Sciences: 2 fractional works · 9.1% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 5.2% of its workMolecular Biology: 1 fractional works · 3.1% of its workGenetics: 0 fractional works · 1.1% of its workBiotechnology: 0 fractional works · 1.0% of its workImmunology and Microbiology: 1 fractional works · 3.5% of its workImmunology: 1 fractional works · 3.5% of its workAgricultural and Biological Sciences: 0 fractional works · 0.4% of its workAnimal Science and Zoology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workALL ITS WORKAlmavivA (Italy)19fractional works, all years
Life Sciences9%Physical Sciences57%Health Sciences11%Social Sciences23%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Computer Science527.3%
    2. Engineering212.8%
    3. Environmental Science211.2%
    4. Earth and Planetary Sciences15.9%
    1. Social Sciences315.5%
    2. Business, Management and Accounting14.9%
    3. Economics, Econometrics and Finance02.4%
    4. Decision Sciences00.4%
    1. Medicine210.5%
    1. Biochemistry, Genetics and Molecular Biology15.2%
    2. Immunology and Microbiology13.5%
    3. Agricultural and Biological Sciences00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.15× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.21× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 3.44× its world share, 0 worksImmunology and Micro…Computer Science: 4.09× its world share, 3 worksComputer ScienceEarth and Planetary Sciences: 5.24× its world share, 1 worksEarth and Planetary …Engineering: 0.97× its world share, 2 worksEngineeringEnvironmental Science: 3.36× its world share, 2 worksEnvironmental ScienceMedicine: 0.45× its world share, 1 worksMedicineBusiness, Management and Accounting: 0.32× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.06× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.66× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Earth and Planetary Sciences, 5.2×. Every wedge is a field page.

All 11 fields, with their numbers
  1. Earth and Planetary Sciences5.24×1 works
  2. Computer Science4.09×3 works
  3. Immunology and Microbiology3.44×0 works
  4. Environmental Science3.36×2 works
  5. Biochemistry, Genetics and Molecular Biology1.21×1 works
  6. Engineering0.97×2 works
  7. Social Sciences0.66×1 works
  8. Medicine0.45×1 works
  9. Business, Management and Accounting0.32×0 works
  10. Agricultural and Biological Sciences0.15×0 works
  11. Economics, Econometrics and Finance0.06×0 works

What are the most cited papers from AlmavivA (Italy)?

The most cited paper from AlmavivA (Italy) is "Neoantigen cancer vaccine augments anti-CTLA-4 efficacy" (Erika Salvatori, Lucia Lione, Mirco Compagnone et al., 2022), with 53 citations. Next come "Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth" (44) and "Overexpression of HER ‐2 via immunohistochemistry in canine urinary bladder transitional cell carcinoma ‐ A marker of malignancy and possible therapeutic target" (33).

Most cited papers
#PaperReleasedCitations
1 Neoantigen cancer vaccine augments anti-CTLA-4 efficacy Erika Salvatori, Lucia Lione, Mirco Compagnone et al. · npj Vaccines Open access 2 Feb 2022 53
2 Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth Luigi Aurisicchio, Erika Salvatori, Lucia Lione et al. · Journal of Experimental & Clinical Cancer Research Open access 14 Feb 2019 44
3 Overexpression of HER ‐2 via immunohistochemistry in canine urinary bladder transitional cell carcinoma ‐ A marker of malignancy and possible therapeutic target Francesca Millanta, Joseph A. Impellizeri, Leo J. McSherry et al. · Veterinary and Comparative Oncology Open access 4 Sep 2017 33
4 Antitumor efficacy of a neoantigen cancer vaccine delivered by electroporation is influenced by microbiota composition Lucia Lione, Erika Salvatori, Adriana Petrazzuolo et al. · OncoImmunology Open access 2021 27
5 A Proposal for Automatic Coastline Extraction from Landsat 8 OLI Images Combining Modified Optimum Index Factor (MOIF) and K-Means Francesco Giuseppe Figliomeni, Francesca Guastaferro, Claudio Parente et al. · Remote Sensing Open access 19 Jun 2023 22
All 40 most cited papers, with filters and sorting

Which research topics does AlmavivA (Italy) publish most on?

By volume in 2022-now: Remote Sensing and LiDAR Applications, CAR-T cell therapy research, Immunotherapy and Immune Responses and Remote-Sensing Image Classification.

Remote Sensing and LiDAR…1Remote Sensing and LiDAR Applications: 1 fractional worksCAR-T cell therapy research: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksRemote-Sensing Image Classification: 0 fractional works3D Surveying and Cultural Heritage: 0 fractional worksQuantum Computing Algorithms and Architecture: 0 fractional worksExplainable Artificial I…0Explainable Artificial Intelligence (XAI): 0 fractional worksChaos-based Image/Signal Encryption: 0 fractional worksAdversarial Robustness in Machine Learning: 0 fractional worksCryptography and Data Se…0Cryptography and Data Security: 0 fractional works
Environmental EngineeringOncologyImmunologyMedia Technology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Remote Sensing and LiDAR Applications Environmental Engineering 1 works
  2. 2 CAR-T cell therapy research Oncology 0 works
  3. 3 Immunotherapy and Immune Responses Immunology 0 works
  4. 4 Remote-Sensing Image Classification Media Technology 0 works
  5. 5 3D Surveying and Cultural Heritage Geology 0 works
  6. 6 Quantum Computing Algorithms and Architecture Artificial Intelligence 0 works
  7. 7 Explainable Artificial Intelligence (XAI) Artificial Intelligence 0 works
  8. 8 Chaos-based Image/Signal Encryption Computer Vision and Pattern Recognition 0 works
  9. 9 Adversarial Robustness in Machine Learning Artificial Intelligence 0 works
  10. 10 Cryptography and Data Security Artificial Intelligence 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available43.4%not open56.6%

World: 40% of research is openly available.

with international co-authors15.3%domestic only84.7%

World: 18% is written across borders.

How has AlmavivA (Italy)'s research output changed?

Output in 2022-2025 was 196% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is AlmavivA (Italy) as a percentage of every work published that year, 0.000039% in 2024.

still counting0.000050%0.00010%AlmavivA (Italy)0.000081% in 202520102020

Fractional works of AlmavivA (Italy) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Rome

All research institutions in Rome

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about AlmavivA (Italy). Posts are plain text and can be reported.